Table 1 Hepatitis C Virus burden, total health expenditure and cost of HCV treatment in seven African countries
Country | Total HCV population (000,000)a | Total expenditure on health as % of GDP (2014) (WHO)b | Total expenditure on health (000,000) (2014) (WHO)b | Cost of 12- weeks regimen of DAA per patientc | Total cost of 12- weeks regimen of DAA (000,000) | Cost of 12-weeks DAA as % of total health expenditure | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Â | Â | Â | Â | Â | Â | For universal (100%) DAA coverage | For 80% DAA coverage | For universal (100%) DAA coverage | For 80% DAA coverage | ||||
| Â | Â | Â | Â | Generic | Originator | Generic | Originator | Generic | Originator | Generic | Originator | Generic | Originator |
Egypt | 8.306 | 5.6% | 18,524 | $684 | $1200 | $5681.3 | $9967.2 | $4545.0 | $7973.8 | 31% | 54% | 25% | 43% |
Ethiopia | 0.676 | 4.9% | 3015 | $750 | $1200 | $507.0 | $811.2 | $405.6 | $649.0 | 17% | 27% | 13% | 22% |
Nigeria | 8.115 | 3.7% | 17,800 | $750 | $1200 | $6086.3 | $9738.0 | $4869.0 | $7790.4 | 34% | 55% | 27% | 44% |
DRC | 0.11 | 4.3% | 1515 | $750 | $1200 | $82.5 | $132.0 | $66.0 | $105.6 | 5% | 9% | 4% | 7% |
Cameroon | 1.473 | 4.1% | 1197 | $750 | $1200 | $1104.8 | $1767.6 | $883.8 | $1414.1 | 92% | 148% | 74% | 118% |
Rwanda | 0.475 | 7.5% | 607 | $750 | $1200 | $356.3 | $570.0 | $285.0 | $456.0 | 59% | 94% | 47% | 75% |
South Africa | 0.633 | 8.8% | 27,519 | $750 | $1200 | $474.8 | $759.6 | $379.8 | $607.7 | 2% | 3% | 1% | 2% |